摘要
本文系统梳理了洪湖万氏疮疡疗法的历史渊源与学术体系。其核心理论认为“气血瘀滞”为发病之本,确立“托里透毒”“化腐生肌”为基本治则。在诊疗特色方面,形成了明确的辨证分期治疗模式:初期以清热解毒为主,成脓期重在托毒排脓,溃后期强调生肌收口;同时配合外治药物“疮愈散”分期调配应用,并采取隔日换药的操作规范。临床观察纳入43例体表溃疡患者,结果显示全部病例均获得愈合,其中一般溃疡愈合时间为20–30天,慢性溃疡为40–98天,提示该疗法具有良好的临床疗效。在非物质文化遗产传承层面,当前仍面临传承人匮乏、技术规范不足及循证医学证据缺乏等问题。未来应通过建立系统化病例数据库、开展多中心临床研究及推进制剂标准化等措施,以促进该疗法的规范化传承与创新发展。
关键词: 洪湖万氏疮疡疗法;中医外科;非物质文化遗产;疮疡;传承保护
Abstract
This study systematically reviews the historical origins and academic framework of the Wanshi therapy for sores and ulcers in Honghu. Its core theoretical foundation identifies “qi and blood stasis” as the fundamental pathogenesis, with “tonifying the interior and expelling toxins” and “removing necrotic tissue to promote tissue regeneration” as the principal therapeutic strategies. In terms of clinical practice, a stage-based syndrome differentiation approach has been established, including heat-clearing and detoxification in the early stage, toxin expulsion and pus drainage in the suppuration stage, and tissue regeneration and wound closure in the ulcer-healing stage. This is complemented by the staged application of the external preparation Chuangyusan and a standardized regimen of alternate-day dressing changes. Clinical observations involving 43 patients with superficial ulcers demonstrated complete wound healing in all cases. The healing time ranged from 20–30 days for common ulcers and 40–98 days for chronic ulcers, indicating favorable therapeutic outcomes. From the perspective of intangible cultural heritage preservation, this therapy currently faces challenges such as a shortage of qualified inheritors, lack of standardized technical protocols, and insufficient evidence from evidence-based medicine. Future efforts should focus on establishing systematic case databases, conducting multicenter clinical studies, and promoting the standardization of formulations to facilitate its sustainable inheritance and innovative development.
Key words: Wanshi therapy for sores and ulcers; Traditional Chinese medicine surgery; Intangible cultural heritage; Chronic wounds; Inheritance and protection
参考文献 References
[1] 罗颂平.中医学术流派与师承教育是中医生存与发展的重要模式[J].中华中医药杂志,2014,29(11):3361-3363.
[2] 笪巍伟,薛纯纯,张树瑛,等.基于海派伤科发展历程探索“同中存异”流派传承新模式的构建[J].上海中医药杂志,2025,59(01):24-27+32.
[3] 万波,万良超,汪草原.万氏疮愈散外敷并中药内服治愈体表溃疡疗效分析[C]//中国中西医结合学会疡科分会.中国中西医结合学会疡科分会第十一次全国学术交流会论文汇编,2003:57-58.
[4] Sen CK. Human Wound and Its Burden: Updated 2020 Compendium of Estimates. Adv Wound Care (New Rochelle). 2021 May;10(5):281-292.
[5] Mamun AA, Shao C, Geng P, Wang S, Xiao J. Recent advances in molecular mechanisms of skin wound healing and its treatments. Front Immunol. 2024 May 21;15: 1395479.
[6] Järbrink K, Ni G, Sönnergren H, Schmidtchen A, Pang C, Bajpai R, Car J. Prevalence and incidence of chronic wounds and related complications: a protocol for a systematic review. Syst Rev. 2016 Sep 8;5(1):152.
[7] Lo ZJ, Surendra NK, Saxena A, Car J. Clinical and economic burden of diabetic foot ulcers: A 5-year longitudinal multi-ethnic cohort study from the tropics. Int Wound J. 2021 Jun;18(3):375-386.
[8] Ramos AN, Cerusico N, Chavez-Jara R. Rethinking Chronic Wound Treatment: Unlocking the Potential of Combination Products for an Unmet Multifactorial Need: A Review Study. Health Sci Rep. 2026 Feb 8;9(2):e71798.
[9] Wang L, Sheng C, Liu J, Chen R, Yue R, Yang M, Hu Z. Integrated treatment utilizing both Chinese and Western medicine for refractory diabetic foot ulcers: a case report. Front Endocrinol (Lausanne). 2025 Nov 5;16:1704770.
[10] Fernández-Guarino M, Hernández-Bule ML, Bacci S. Cellular and Molecular Processes in Wound Healing. Biomedicines. 2023 Sep 13;11(9):2526.
[11] Roman J. Fibroblasts-Warriors at the Intersection of Wound Healing and Disrepair. Biomolecules. 2023 Jun 6;13(6):945.